TY - JOUR
T1 - Clinical impact of epithelial types on postoperative outcomes for intraductal papillary mucinous neoplasms
T2 - a multicenter retrospective study
AU - Yamashige, Daiki
AU - Hijioka, Susumu
AU - Shimizu, Yasuhiro
AU - Yanagisawa, Akio
AU - Nakamura, Masafumi
AU - Hara, Kazuo
AU - Kitano, Masayuki
AU - Koshita, Shinsuke
AU - Takikawa, Tetsuya
AU - Kin, Toshifumi
AU - Takenaka, Mamoru
AU - Hanada, Keiji
AU - Ueki, Toshiharu
AU - Itoi, Takao
AU - Yamada, Reiko
AU - Ohtsuka, Takao
AU - Hirono, Seiko
AU - Kanno, Atsushi
AU - Takeyama, Yoshifumi
AU - Masamune, Atsushi
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Japanese Society of Gastroenterology 2025.
PY - 2025/5
Y1 - 2025/5
N2 - Background: Intraductal papillary mucinous neoplasms (IPMNs) are classified into three epithelial types with distinct biological behaviors. However, their effects on the postoperative outcomes remain unclear. Methods: This multicenter retrospective study included 556 patients with IPMNs who underwent surgical resection. The epithelial types were categorized into the gastric (n = 323), intestinal (n = 160), and pancreatobiliary (n = 73) types. Their associations with the development of extrapancreatic lesions; remnant high-risk lesions (HRLs), including metachronous pancreatic ductal adenocarcinoma (PDAC); and disease-specific survival (DSS) were analyzed. Results: Fifty-one patients (9.2%) developed extrapancreatic lesions. The 10-year cumulative incidence rates for the gastric, intestinal, and pancreatobiliary types were 9.3%, 9.1%, and 32.0%, respectively (P < 0.001). Multivariate analysis identified invasive carcinoma, the gastric, and pancreatobiliary types as independent predictors. Among 516 patients who did not undergo total pancreatectomy, 40 (7.8%) and 13 (2.5%) developed HRLs and metachronous PDAC, respectively. The 10-year cumulative incidence rates of HRLs and metachronous PDAC for the gastric, intestinal, and pancreatobiliary types were 7.0%, 16.2%, and 37.2% and 1.8%, 3.7%, and 22.7%, respectively (P = 0.001 and P = 0.012). In multivariate analysis, the pancreatobiliary type was an independent predictor of metachronous PDAC. Five-year DSS rates for the gastric, intestinal, and pancreatobiliary types were 92.5%, 96.0%, and 76.1% (P < 0.001), respectively. Multivariate analysis identified invasive carcinoma, the gastric, and pancreatobiliary types as independent prognostic factors for DSS. Conclusions: IPMN epithelial type can independently affect postoperative outcomes. In particular, the pancreatobiliary type has significant impact on the development of metachronous PDAC. Therefore, postoperative surveillance should be tailored according to the epithelial type.
AB - Background: Intraductal papillary mucinous neoplasms (IPMNs) are classified into three epithelial types with distinct biological behaviors. However, their effects on the postoperative outcomes remain unclear. Methods: This multicenter retrospective study included 556 patients with IPMNs who underwent surgical resection. The epithelial types were categorized into the gastric (n = 323), intestinal (n = 160), and pancreatobiliary (n = 73) types. Their associations with the development of extrapancreatic lesions; remnant high-risk lesions (HRLs), including metachronous pancreatic ductal adenocarcinoma (PDAC); and disease-specific survival (DSS) were analyzed. Results: Fifty-one patients (9.2%) developed extrapancreatic lesions. The 10-year cumulative incidence rates for the gastric, intestinal, and pancreatobiliary types were 9.3%, 9.1%, and 32.0%, respectively (P < 0.001). Multivariate analysis identified invasive carcinoma, the gastric, and pancreatobiliary types as independent predictors. Among 516 patients who did not undergo total pancreatectomy, 40 (7.8%) and 13 (2.5%) developed HRLs and metachronous PDAC, respectively. The 10-year cumulative incidence rates of HRLs and metachronous PDAC for the gastric, intestinal, and pancreatobiliary types were 7.0%, 16.2%, and 37.2% and 1.8%, 3.7%, and 22.7%, respectively (P = 0.001 and P = 0.012). In multivariate analysis, the pancreatobiliary type was an independent predictor of metachronous PDAC. Five-year DSS rates for the gastric, intestinal, and pancreatobiliary types were 92.5%, 96.0%, and 76.1% (P < 0.001), respectively. Multivariate analysis identified invasive carcinoma, the gastric, and pancreatobiliary types as independent prognostic factors for DSS. Conclusions: IPMN epithelial type can independently affect postoperative outcomes. In particular, the pancreatobiliary type has significant impact on the development of metachronous PDAC. Therefore, postoperative surveillance should be tailored according to the epithelial type.
KW - Disease-specific survival
KW - Epithelial type
KW - Intraductal papillary mucinous neoplasm
KW - Metachronous pancreatic ductal adenocarcinoma
KW - Pancreatobiliary type
UR - http://www.scopus.com/inward/record.url?scp=85219687426&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85219687426&partnerID=8YFLogxK
U2 - 10.1007/s00535-025-02225-z
DO - 10.1007/s00535-025-02225-z
M3 - Article
C2 - 39966119
AN - SCOPUS:85219687426
SN - 0944-1174
VL - 60
SP - 658
EP - 670
JO - Journal of Gastroenterology
JF - Journal of Gastroenterology
IS - 5
ER -